Evidence for a Nonspecific Factor Interfering in the Radioimmunoassay of Somatoliberin-Like Immunoreactivity in Human Seminal Plasma

M. Losa, G. Wolfram, J. Schopohl, S. Sobieszczyk, K. von Werder

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In the present study we investigated the nature of somatoliberin-like immunoreactivity in human seminal plasma. In unextracted seminal plasma, somatoliberin-like immunoreactivity represented 3.8 (μg/1 somatoliberin, with a dilution curve that ran almost completely parallel to that of synthetic somatoliberin standard. After extraction by adsorption on hydrophobic C 18 Sep-pak cartridges or immunoaffinity chromatography, no somatoliberin-like immunoreactivity in seminal plasma could be detected. After gel permeation chromatography on a Sephadex G-50 fine column, all somatoliberin-like immunoreactivity of unextracted seminal plasma was recovered at the void volume of the column. When equal volumes of unextracted seminal plasma and radioiodinated somatoliberin were coincubated for two days at 4 °C, gel chromatography revealed the disappearance of the normal [125I]somatoliberm peak, replaced by a new peak eluting shortly after the total volume of the column. When unextracted seminal plasma was heated at 90 °C for 10 min or submitted to ultrafiltration, the interfering factor was no longer detectable. Our data show that enzymic degradation of radioiodinated somatoliberin led to misleadingly high concentrations of somatoliberin-like immunoreactivity in seminal plasma. These phenomena should therefore be considered when performing radioimmunoassays of short chain peptides in biological fluids.

Original languageEnglish
Pages (from-to)367-372
Number of pages6
JournalClinical Chemistry and Laboratory Medicine
Volume26
Issue number6
DOIs
Publication statusPublished - 1988

Fingerprint

Plasma (human)
Growth Hormone-Releasing Hormone
Semen
Radioimmunoassay
Plasmas
Chromatography
Gel Chromatography
Ultrafiltration
Gel permeation chromatography
Dilution
Adsorption
Gels
Degradation
Peptides

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Evidence for a Nonspecific Factor Interfering in the Radioimmunoassay of Somatoliberin-Like Immunoreactivity in Human Seminal Plasma. / Losa, M.; Wolfram, G.; Schopohl, J.; Sobieszczyk, S.; von Werder, K.

In: Clinical Chemistry and Laboratory Medicine, Vol. 26, No. 6, 1988, p. 367-372.

Research output: Contribution to journalArticle

@article{b11490a75df547be842a740ff595addd,
title = "Evidence for a Nonspecific Factor Interfering in the Radioimmunoassay of Somatoliberin-Like Immunoreactivity in Human Seminal Plasma",
abstract = "In the present study we investigated the nature of somatoliberin-like immunoreactivity in human seminal plasma. In unextracted seminal plasma, somatoliberin-like immunoreactivity represented 3.8 (μg/1 somatoliberin, with a dilution curve that ran almost completely parallel to that of synthetic somatoliberin standard. After extraction by adsorption on hydrophobic C 18 Sep-pak cartridges or immunoaffinity chromatography, no somatoliberin-like immunoreactivity in seminal plasma could be detected. After gel permeation chromatography on a Sephadex G-50 fine column, all somatoliberin-like immunoreactivity of unextracted seminal plasma was recovered at the void volume of the column. When equal volumes of unextracted seminal plasma and radioiodinated somatoliberin were coincubated for two days at 4 °C, gel chromatography revealed the disappearance of the normal [125I]somatoliberm peak, replaced by a new peak eluting shortly after the total volume of the column. When unextracted seminal plasma was heated at 90 °C for 10 min or submitted to ultrafiltration, the interfering factor was no longer detectable. Our data show that enzymic degradation of radioiodinated somatoliberin led to misleadingly high concentrations of somatoliberin-like immunoreactivity in seminal plasma. These phenomena should therefore be considered when performing radioimmunoassays of short chain peptides in biological fluids.",
author = "M. Losa and G. Wolfram and J. Schopohl and S. Sobieszczyk and {von Werder}, K.",
year = "1988",
doi = "10.1515/cclm.1988.26.6.367",
language = "English",
volume = "26",
pages = "367--372",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "6",

}

TY - JOUR

T1 - Evidence for a Nonspecific Factor Interfering in the Radioimmunoassay of Somatoliberin-Like Immunoreactivity in Human Seminal Plasma

AU - Losa, M.

AU - Wolfram, G.

AU - Schopohl, J.

AU - Sobieszczyk, S.

AU - von Werder, K.

PY - 1988

Y1 - 1988

N2 - In the present study we investigated the nature of somatoliberin-like immunoreactivity in human seminal plasma. In unextracted seminal plasma, somatoliberin-like immunoreactivity represented 3.8 (μg/1 somatoliberin, with a dilution curve that ran almost completely parallel to that of synthetic somatoliberin standard. After extraction by adsorption on hydrophobic C 18 Sep-pak cartridges or immunoaffinity chromatography, no somatoliberin-like immunoreactivity in seminal plasma could be detected. After gel permeation chromatography on a Sephadex G-50 fine column, all somatoliberin-like immunoreactivity of unextracted seminal plasma was recovered at the void volume of the column. When equal volumes of unextracted seminal plasma and radioiodinated somatoliberin were coincubated for two days at 4 °C, gel chromatography revealed the disappearance of the normal [125I]somatoliberm peak, replaced by a new peak eluting shortly after the total volume of the column. When unextracted seminal plasma was heated at 90 °C for 10 min or submitted to ultrafiltration, the interfering factor was no longer detectable. Our data show that enzymic degradation of radioiodinated somatoliberin led to misleadingly high concentrations of somatoliberin-like immunoreactivity in seminal plasma. These phenomena should therefore be considered when performing radioimmunoassays of short chain peptides in biological fluids.

AB - In the present study we investigated the nature of somatoliberin-like immunoreactivity in human seminal plasma. In unextracted seminal plasma, somatoliberin-like immunoreactivity represented 3.8 (μg/1 somatoliberin, with a dilution curve that ran almost completely parallel to that of synthetic somatoliberin standard. After extraction by adsorption on hydrophobic C 18 Sep-pak cartridges or immunoaffinity chromatography, no somatoliberin-like immunoreactivity in seminal plasma could be detected. After gel permeation chromatography on a Sephadex G-50 fine column, all somatoliberin-like immunoreactivity of unextracted seminal plasma was recovered at the void volume of the column. When equal volumes of unextracted seminal plasma and radioiodinated somatoliberin were coincubated for two days at 4 °C, gel chromatography revealed the disappearance of the normal [125I]somatoliberm peak, replaced by a new peak eluting shortly after the total volume of the column. When unextracted seminal plasma was heated at 90 °C for 10 min or submitted to ultrafiltration, the interfering factor was no longer detectable. Our data show that enzymic degradation of radioiodinated somatoliberin led to misleadingly high concentrations of somatoliberin-like immunoreactivity in seminal plasma. These phenomena should therefore be considered when performing radioimmunoassays of short chain peptides in biological fluids.

UR - http://www.scopus.com/inward/record.url?scp=84942398847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942398847&partnerID=8YFLogxK

U2 - 10.1515/cclm.1988.26.6.367

DO - 10.1515/cclm.1988.26.6.367

M3 - Article

VL - 26

SP - 367

EP - 372

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 6

ER -